A screening program at emergency departments may help to more efficiently diagnose acute forms of porphyria, according to a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Treatment with the implantable medication Scenesse (afamelanotide), which is approved to help reduce light intolerance in people with erythropoietic…
When patients have unusual sunlight sensitivity combined with liver damage, the possible diagnosis of erythropoietic protoporphyria (EPP) should be…
Four cases of children diagnosed with porphyria were described in a recent report where researchers highlighted that, while porphyria…
For a teenage boy in Japan, it wasn’t until getting a second liver biopsy — nearly three years after his…
In an extremely unusual case, a young man in Turkey diagnosed as a child with spinal muscular atrophy, a rare…
Treatment with Givlaari (givosiran) normalized disease-related laboratory parameters in a 47-year-old woman with acute intermittent porphyria (AIP) but…
Among people with porphyria cutanea tarda (PCT) and chronic hepatitis C infection, treatment with modern antiviral medicines has been…
People with inactive porphyria who choose to fast for a day as part of their religious observances generally don’t…
Treatment with Scenesse (afamelanotide) — an implantable medicine used to treat people with intolerance to light — can help…